Will Triomics secure an additional funding round of at least $15 million by December 31, 2028?

Triomics has just raised $22M, indicating strong investor confidence in their AI oncology platform. Given the high capital requirements for scaling AI in healthcare and the potential for rapid growth, another significant funding round within two years is plausible.

Implied probability (Yes)

60%

Closes

2030-08-25